Johnson & Johnson (JNJ) Shares Bought by Whittier Trust Co

Author

31 August, 2017

Vetr cut shares of Johnson & Johnson from a "buy" rating to a "hold" rating and set a $128.54 target price on the stock.in a research note on Monday, May 1st. The company has market cap of $1.52 million. Investors of record on Tuesday, August 29th will be given a $0.84 dividend. The stock traded at a volume of 1.44 million shares. Agora Holdings Inc (OTCMKTS:AGHI) has 0.00% since August 30, 2016 and is. It has underperformed by 3.04% the S&P500. Signature Financial Management Inc sold 3,959 shares as Johnson & Johnson (JNJ)'s stock rose 6.85%. Lenox Wealth Advisors Inc. boosted its position in shares of Johnson & Johnson by 0.7% in the first quarter. Forester Capital Management Ltd who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $353.46B market cap company. The stock declined 0.42% or $0.56 reaching $131.65 on the news. About 11,485 shares traded.

HPM Partners LLC raised its position in shares of Johnson & Johnson (NYSE:JNJ) by 2,516.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). It has underperformed by 4.16% the S&P500.

Nokomis Capital Llc, which manages about $289.90M and $461.50M US Long portfolio, decreased its stake in Spdr S&P 500 Etf Tr (Put) (SPY) by 102,800 shares to 26,900 shares, valued at $6.01M in 2016Q4, according to the filing.

Minnesota-based Gradient Investments has invested 0.47% in Johnson & Johnson (NYSE:JNJ). Its up 0.12, from 0.82 in 2016Q3. It turned negative, as 12 investors sold LORL shares while 31 reduced holdings. Segall Bryant Hamill Limited Liability Company invested in 1.03M shares or 0.92% of the stock. Moreover, Van Cleef Asset Managementinc has 0.18% invested in Emerson Electric Co. Moreover, Sit has 0.01% invested in Emerson Electric Co. West Chester Capital Advisors Inc owns 17,912 shares or 0.28% of their United States portfolio. Sheffield Asset Management Llc sold 9,000 shares as Monsanto Co New (MON)'s stock rose 6.51%. First Manhattan Com reported 2.59M shares. Bennicas & Associate Inc stated it has 9,425 shares or 0.98% of all its holdings. Arrow Financial, a New York-based fund reported 61,917 shares. Webster National Bank & Trust N A reported 1.32% stake. Fisher Asset Mgmt reported 10.96 million shares. The legal version of this article can be read at https://www.truebluetribune.com/2017/08/30/hpm-partners-llc-acquires-62967-shares-of-johnson-johnson-jnj.html. Following the transaction, the vice president now owns 230,342 shares in the company, valued at $30,667,733.88. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Forbes.com and their article: "New Data Could Add $1.5 Billion To Sales Of Johnson & Johnson Blood Thinner" published on August 27, 2017 as well as Seekingalpha.com's news article titled: "Johnson & Johnson Is Doing Just Fine" with publication date: August 24, 2017. Finally, Jefferies Group LLC restated a "hold" rating and set a $140.00 target price on shares of Johnson & Johnson in a research note on Friday, June 16th. Therefore 45% are positive. On average, analysts forecast that Johnson & Johnson will post $7.18 EPS for the current fiscal year. Ancora Advsr has invested 0.9% of its portfolio in Johnson & Johnson (NYSE:JNJ). UBS AG reaffirmed a "buy" rating and set a $136.00 price objective on shares of Johnson & Johnson in a research report on Monday, May 15th. The firm earned "Buy" rating on Wednesday, July 20 by Argus Research. The firm has "Hold" rating given on Tuesday, July 18 by Piper Jaffray. RBC Capital Markets maintained the shares of JNJ in report on Wednesday, January 25 with "Outperform" rating. Finally, BidaskClub upgraded Johnson & Johnson from a "buy" rating to a "strong-buy" rating in a research report on Saturday, June 17th. The stock of Monsanto Company (NYSE:MON) earned "Overweight" rating by JP Morgan on Wednesday, September 21. Johnson & Johnson presently has an average rating of "Hold" and an average price target of $133.91. As per Thursday, October 8, the company rating was maintained by UBS.

Investors sentiment increased to 1 in 2016 Q4. Its down 0.06, from 1.04 in 2016Q3.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Natl Bank Of Montreal Can reported 21,244 shares. Beach Counsel Inc Pa stated it has 3.73% of its portfolio in Johnson & Johnson (NYSE:JNJ). Berkshire Asset Limited Co Pa invested 2.71% of its portfolio in Johnson & Johnson (NYSE:JNJ). Hugh Johnson Advsrs Limited Liability Corporation accumulated 0.28% or 7,030 shares. California Employees Retirement Systems reported 6.65M shares. Bowen Hanes And Incorporated reported 1.92% stake. Davenport And Limited Liability, Virginia-based fund reported 14,221 shares. Cadence Capital Mngmt Ltd Liability Co has invested 1% of its portfolio in Johnson & Johnson (NYSE:JNJ). Transamerica Advsrs invested in 3 shares or 0% of the stock. Lbmc Investment Advisors LLC raised its position in Johnson & Johnson by 0.4% in the first quarter.


More news